Cargando…

Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes

OBJECTIVE: This study aimed to compare the quality of life (QoL) in patients with type 2 diabetes using two WHOQoL -BREF and SF-36 questionnaires in Iran. PATIENTS AND METHODS: In this cross-sectional study, 1847 patients with type 2 diabetes were recruited from rural health-care centers affiliated...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbasi-Ghahramanloo, Abbas, Soltani-Kermanshahi, Mojtaba, Mansori, Kamyar, Khazaei-Pool, Maryam, Sohrabi, Masoudreza, Baradaran, Hamid Reza, Talebloo, Zahra, Gholami, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434519/
https://www.ncbi.nlm.nih.gov/pubmed/32884330
http://dx.doi.org/10.2147/IJGM.S258953
_version_ 1783572164531716096
author Abbasi-Ghahramanloo, Abbas
Soltani-Kermanshahi, Mojtaba
Mansori, Kamyar
Khazaei-Pool, Maryam
Sohrabi, Masoudreza
Baradaran, Hamid Reza
Talebloo, Zahra
Gholami, Ali
author_facet Abbasi-Ghahramanloo, Abbas
Soltani-Kermanshahi, Mojtaba
Mansori, Kamyar
Khazaei-Pool, Maryam
Sohrabi, Masoudreza
Baradaran, Hamid Reza
Talebloo, Zahra
Gholami, Ali
author_sort Abbasi-Ghahramanloo, Abbas
collection PubMed
description OBJECTIVE: This study aimed to compare the quality of life (QoL) in patients with type 2 diabetes using two WHOQoL -BREF and SF-36 questionnaires in Iran. PATIENTS AND METHODS: In this cross-sectional study, 1847 patients with type 2 diabetes were recruited from rural health-care centers affiliated to Neyshabur County (Iran) in 2012. In addition to demographic information, two questionnaires WHOQoL-BREF and SF-36 questionnaires were used for data collection. Cronbach’s alpha coefficient was used for scale reliability. We conducted an exploratory factor analysis for the investigation of construct validity. Convergent and discriminant validity were analyzed using Spearman correlation coefficient. To determine the relationships between the eight domains of SF-36 and four domains of the WHOQoL-BREF, structural equation modelling was performed. RESULTS: Cronbach’s alpha coefficients were acceptable for all domains of both WHOQoL-BREF (0.69–0.86) and SF-36 (0.63 −0.92) questionnaires. The principal component analysis showed two separate factors: one for all domains of SF-36 and another for all domains of WHOQoL-BREF. Spearman correlation coefficients of both instruments were partly to strongly correlated with most domains (r ≥0.40). Correlations for domains with similar constructs were stronger than those measuring varied constructs. Structural equation modelling recommended approximately moderate relationships among the SF-36 and WHOQoL-BREF domains. CONCLUSION: Our study suggests that SF-36 and WHOQoL-BREF are reliable instruments for clinical and research uses, respectably. However, results of the goodness of fit showed that the WHOQoL-BREF was fitted well. Also, the WHOQoL-BREF can be considered more suitable for the study population.
format Online
Article
Text
id pubmed-7434519
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-74345192020-09-02 Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes Abbasi-Ghahramanloo, Abbas Soltani-Kermanshahi, Mojtaba Mansori, Kamyar Khazaei-Pool, Maryam Sohrabi, Masoudreza Baradaran, Hamid Reza Talebloo, Zahra Gholami, Ali Int J Gen Med Original Research OBJECTIVE: This study aimed to compare the quality of life (QoL) in patients with type 2 diabetes using two WHOQoL -BREF and SF-36 questionnaires in Iran. PATIENTS AND METHODS: In this cross-sectional study, 1847 patients with type 2 diabetes were recruited from rural health-care centers affiliated to Neyshabur County (Iran) in 2012. In addition to demographic information, two questionnaires WHOQoL-BREF and SF-36 questionnaires were used for data collection. Cronbach’s alpha coefficient was used for scale reliability. We conducted an exploratory factor analysis for the investigation of construct validity. Convergent and discriminant validity were analyzed using Spearman correlation coefficient. To determine the relationships between the eight domains of SF-36 and four domains of the WHOQoL-BREF, structural equation modelling was performed. RESULTS: Cronbach’s alpha coefficients were acceptable for all domains of both WHOQoL-BREF (0.69–0.86) and SF-36 (0.63 −0.92) questionnaires. The principal component analysis showed two separate factors: one for all domains of SF-36 and another for all domains of WHOQoL-BREF. Spearman correlation coefficients of both instruments were partly to strongly correlated with most domains (r ≥0.40). Correlations for domains with similar constructs were stronger than those measuring varied constructs. Structural equation modelling recommended approximately moderate relationships among the SF-36 and WHOQoL-BREF domains. CONCLUSION: Our study suggests that SF-36 and WHOQoL-BREF are reliable instruments for clinical and research uses, respectably. However, results of the goodness of fit showed that the WHOQoL-BREF was fitted well. Also, the WHOQoL-BREF can be considered more suitable for the study population. Dove 2020-08-11 /pmc/articles/PMC7434519/ /pubmed/32884330 http://dx.doi.org/10.2147/IJGM.S258953 Text en © 2020 Abbasi-Ghahramanloo et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Abbasi-Ghahramanloo, Abbas
Soltani-Kermanshahi, Mojtaba
Mansori, Kamyar
Khazaei-Pool, Maryam
Sohrabi, Masoudreza
Baradaran, Hamid Reza
Talebloo, Zahra
Gholami, Ali
Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes
title Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes
title_full Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes
title_fullStr Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes
title_full_unstemmed Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes
title_short Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes
title_sort comparison of sf-36 and whoqol-bref in measuring quality of life in patients with type 2 diabetes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434519/
https://www.ncbi.nlm.nih.gov/pubmed/32884330
http://dx.doi.org/10.2147/IJGM.S258953
work_keys_str_mv AT abbasighahramanlooabbas comparisonofsf36andwhoqolbrefinmeasuringqualityoflifeinpatientswithtype2diabetes
AT soltanikermanshahimojtaba comparisonofsf36andwhoqolbrefinmeasuringqualityoflifeinpatientswithtype2diabetes
AT mansorikamyar comparisonofsf36andwhoqolbrefinmeasuringqualityoflifeinpatientswithtype2diabetes
AT khazaeipoolmaryam comparisonofsf36andwhoqolbrefinmeasuringqualityoflifeinpatientswithtype2diabetes
AT sohrabimasoudreza comparisonofsf36andwhoqolbrefinmeasuringqualityoflifeinpatientswithtype2diabetes
AT baradaranhamidreza comparisonofsf36andwhoqolbrefinmeasuringqualityoflifeinpatientswithtype2diabetes
AT talebloozahra comparisonofsf36andwhoqolbrefinmeasuringqualityoflifeinpatientswithtype2diabetes
AT gholamiali comparisonofsf36andwhoqolbrefinmeasuringqualityoflifeinpatientswithtype2diabetes